Patents Assigned to Insucaps Limited
  • Gelated microparticle suitable for oral delivery of therapeutic peptides to the lower intestine
    Patent number: 10092517
    Abstract: A gelated microparticle suitable for delivery intact to the mammalian lower intestine via an oral route comprises a monodispersed matrix formed of at least partially hydrolyzed casein, chitosan, and an active agent, and includes a minor amount of at least one permeation enhancer dispersed throughout the matrix.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: October 9, 2018
    Assignee: Insucaps Limited
    Inventors: Sinead Bleiel, Sam Maher